Retail sale of other food
PROVECTUS PHARMA NORDIC AS
Revenue 2024
NOK 20.2m
Operating profit
NOK 386,000
Equity
NOK 2.2m
Incorporated
2021
Share capital
NOK 120,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 20.2m | |
| Total operating costs | 19.8m | |
| Operating profit (EBIT) | 386k | |
| Net financial items | −130k | |
| Profit for the year | 249k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 9.2m | |
| of which current assets | 9.1m | |
| Equity | 2.2m | |
| Total liabilities | 7.0m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.